Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00209105 · ClinicalTrials.gov registry record
Characterizing Psychological Consequences of Childhood Trauma
A clinical trial of Major Depressive Disorder, sponsored by Emory University.
- Completed
- Registry status
- 113
- Enrollment target
- 1
- Study location
NCT00209105: Completed study of Major Depressive Disorder, sponsored by Emory University.
NCT00209105 is a study of Major Depressive Disorder that has completed, run by Emory University. The registered enrollment target is 113 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00209105, a study of Major Depressive Disorder, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will characterize the mental health consequences of early-life trauma.
Conditions Studied
Interventions
- DRUG DEX-CRF stimulation test
- BEHAVIORAL Psychosocial stress induction
- PROCEDURE Brain imaging of sad mood , self-reference, reward
- BEHAVIORAL Acoustic startle
Study Locations (1)
Georgia
- General Clinical Research Center at Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2005-01 |
| Est. Completion | 2011-03 |
What the finished NCT00209105 record still lists
NCT00209105 is an observational study that tracks outcomes without assigning an intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 4 interventions - of which DEX-CRF stimulation test is the first listed.
NCT00209105 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00209105 about?
NCT00209105 is a clinical study titled "Characterizing Psychological Consequences of Childhood Trauma". This study will characterize the mental health consequences of early-life trauma.
What is the current status of trial NCT00209105?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2005-01. Estimated completion is 2011-03.
What conditions does trial NCT00209105 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT00209105?
The interventions under investigation include: DEX-CRF stimulation test (DRUG), Psychosocial stress induction (BEHAVIORAL), Brain imaging of sad mood , self-reference, reward (PROCEDURE), Acoustic startle (BEHAVIORAL).
Who is sponsoring clinical trial NCT00209105?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00209105 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00209105's enrollment target sits among peer trials
113 125th of 282 higher than 158 of 282 other Major Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Taking Action for College Students
RECRUITING · NA
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia